Kingston, Canada

John R Carran

This inventor holds 5 USPTO granted patents. Top assignee: Queen's University at Kingston. Active years: 2001-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John R Carran. Retrieved from https://idiyas.com/inventor/john-r-carran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 40.0

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2001-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: John R Carran: Innovator in Anti-Epileptic Compounds

Introduction

John R Carran is a notable inventor based in Kingston, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating convulsive disorders such as epilepsy. With a total of 5 patents to his name, Carran's work is recognized for its potential impact on the medical community.

Latest Patents

Carran's latest patents focus on pyrimidine compounds that serve as anti-ictogenic and/or anti-epileptogenic agents. These patents disclose methods and compounds that inhibit or prevent ictogenesis and epileptogenesis. The invention also includes methods for preparing these compounds, which are particularly preferred for their effectiveness in treating convulsive disorders, including epilepsy.

Career Highlights

Throughout his career, John R Carran has been associated with Queen's University at Kingston, where he has contributed to research and development in the field of pharmacology. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Carran has collaborated with esteemed colleagues, including Donald F Weaver and Donald E Weaver. These partnerships have further enhanced the research and development of his patented compounds.

Conclusion

John R Carran's work in developing anti-epileptic compounds showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against convulsive disorders, and his patents reflect a commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…